Health Care Equipment & Services

Stone Warren’s latest NeoGenomics purchase signals confidence in the firm’s defense partnership and silicon‑anode battery tech, hinting at future upside for investors.

Insider buys at Clover Health signal long‑term confidence amid a volatile market – see why CEO Jamie L.’s 159‑k‑share purchase could hint at a rebound.

Insight into Sight Sciences’ latest insider sales: tax‑covered transactions hint at stable confidence but raise pressure; upcoming ASCRS data could spark a rebound.

Insider sales by Jason Krantz and CEO Kevin Coop reveal a strategic trim amid a 57% YTD drop, hinting at portfolio hedging rather than panic in Definitive Healthcare.

Insider buying by Certara’s CCO signals confidence amid a sharp decline, offering investors a nuanced signal as the company seeks governance reforms and growth.

Zimmer Biomet insider buying: Noor Jehanzeb’s RSU and stock purchases signal executive confidence amid a 27.8% drop, hinting at potential upside for long‑term investors.

Teladoc insider moves: Catapano’s RSU conversion and sale show long‑term confidence amid a falling share price—insightful for investors navigating the health‑tech shift.

Humana insider activity shows steady confidence: Shetty Sanjay K added 887 shares, sold 401, keeping 12,544 holdings, signalling long‑term belief in growth.

Okamoto’s zero‑cost option grant signals confidence in Axe Compute’s AI‑driven oncology future and aligns leadership with shareholder value—could the stock be undervalued?

Hinge Health insider Mecklenburg Gabriel M.I. buys 50k shares, signaling executive confidence amid stock volatility and long‑term growth prospects.